Samsung Biologics Launches $1.81 Billion Bid to Acquire PolyPeptide 
Samsung Cuts U.S. Consumer Electronics Jobs as Headquarters Moves to Texas 
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors 
Gold Climbs Above $4,000 as Middle East Tensions and Fed Outlook Drive Safe-Haven Demand 
Saudi Oil Tankers Reverse Course as Houthi Threats Disrupt Red Sea Shipping 
Trump Set to Unveil New Tariffs on Dozens of Countries as Global 10% Duty Nears Expiration 
What’s the difference between baking powder and baking soda? It’s subtle, but significant 
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
How to support someone who is grieving: five research-backed strategies 
AI is driving down the price of knowledge – universities have to rethink what they offer 
Japan PM Sanae Takaichi Unveils Growth Plan as BOJ Independence Concerns Lift Bond Yields 
The Beauty Beneath the Expressway: A Journey from Self to Service 
Asian Currencies Hold Steady as Fed Outlook Offsets Middle East Tensions 
Bank of America Says These Overlooked AI Stocks Could Be the Next Winners 
Asian Stocks Rise as Oil Retreats on Iran Ceasefire Hopes Ahead of Key AI Earnings 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
